44 results on '"Toprak, Umut H."'
Search Results
2. S120: MNX1-ACTIVATING ENHANCER HIJACKING EVENTS IN ACUTE MYELOID LEUKEMIA WITH DELETIONS ON CHROMOSOME 7Q
3. Supplementary Patient Data from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer
4. Supplementary Table S1 from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer
5. Data from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer
6. Supplementary Figure S2 from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer
7. Supplementary Figure S3 from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer
8. Supplementary Table S1 from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer
9. Supplementary Figure S1 from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer
10. Supplementary Table S2 from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer
11. Supplementary Figure S2 from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer
12. Supplementary Table S2 from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer
13. Supplementary Figure S1 from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer
14. Data from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer
15. Supplementary Figure S3 from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer
16. Supplementary Patient Data from NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer
17. Translocation t(6;7) in AML-M4 cell line GDM-1 results in MNX1 activation through enhancer-hijacking
18. Exploration of whole genome and transcriptome sequencing data lacks evidence for oncogenic viral elements to drive the pathogenesis of T-cell prolymphocytic leukemia
19. Focal structural variants revealed by whole genome sequencing disrupt the histone demethylase KDM4C in B-cell lymphomas
20. T‐cell prolymphocytic leukemia is associated with deregulation of oncogenic microRNAs on transcriptional and epigenetic level
21. Comprehensive genomic analysis of refractory multiple myeloma reveals a complex mutational landscape associated with drug resistance and novel therapeutic vulnerabilities
22. Loss of p16INK4a in neuroblastoma cells induces shift to an immature state with mesenchymal characteristics and increases sensitivity to EGFR inhibitors
23. FOXR2 Stabilizes MYCN Protein and Identifies Non–MYCN-Amplified Neuroblastoma Patients With Unfavorable Outcome
24. Single-cell transcriptomic analyses provide insights into the developmental origins of neuroblastoma
25. Kalirin-RAC controls nucleokinetic migration in ADRN-type neuroblastoma
26. Alternative lengthening of telomeres in childhood neuroblastoma from genome to proteome
27. Accurate and efficient detection of gene fusions from RNA sequencing data
28. Super enhancers define regulatory subtypes and cell identity in neuroblastoma
29. Globally altered epigenetic landscape and delayed osteogenic differentiation in H3.3-G34W-mutant giant cell tumor of bone
30. Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastoma
31. Globally altered epigenetic landscape and lagging osteogenic differentiation in H3.3-G34W-mutant giant cell tumor of bone
32. Reconstruction of rearranged T‐cell receptor loci by whole genome and transcriptome sequencing gives insights into the initial steps of T‐cell prolymphocytic leukemia
33. Cryptic insertion of MYC exons 2 and 3 into the immunoglobulin heavy chain locus detected by whole genome sequencing in a case of “MYC-negative” Burkitt lymphoma
34. Mutational patterns and regulatory networks in epigenetic subgroups of meningioma
35. IG-MYC+ neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas
36. Whole genome sequencing puts forward hypotheses on metastasis evolution and therapy in colorectal cancer
37. NRG1 Fusions in KRAS Wild-Type Pancreatic Cancer
38. Screening drug effects in patient‐derived cancer cells links organoid responses to genome alterations
39. Meningiomas induced by low-dose radiation carry structural variants of NF2 and a distinct mutational signature
40. Resolving drug effects in patient-derived cancer cells links organoid responses to genome alterations
41. Abstract 2696: Four new brain tumor entities emerge from molecular classification of CNS-PNETs
42. New Brain Tumor Entities Emerge from Molecular Classification of CNS-PNETs
43. Conserved Peptide Fragmentation as a Benchmarking Tool for Mass Spectrometers and a Discriminating Feature for Targeted Proteomics
44. Modulation of the Chromatin Phosphoproteome by the Haspin Protein Kinase
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.